Following on from the success of our spring webinar and annual conference, PCM Scientific are pleased to announce that the IOTOD (Improving Outcomes in the Treatment of Opioid Dependence) summer webinar will be taking place on Monday 21st June 16:00 BST.
The educational session will be looking at long-acting buprenorphine in the treatment of opioid dependence and striking the balance between greater freedom and strong engagement.
This summer webinar will be led by Dr Julia Lewis alongside Dr Steve Brinksman, where they will discuss the significance of taking a holistic approach when providing treatment for opioid dependence.
The event will also explore the sharing of clinical best-practice involving OST – particularly when using long-acting buprenorphine (LAB) formulations – to support adherence, good quality of life and mental health, and overall treatment success. Both speakers will share their own personal patient stories and the impact this treatment has had on their patients, adding in a case-based element to their talks.
Accessing our community of healthcare professionals via our media brands, the webinar welcomes addiction specialists, psychiatrist and psychologists, GPs, community pharmacists, hepatologists, primary care nurses, hospital pharmacists and other healthcare professional managing patients with opioid dependence and associated comorbidities, from the UK and across Europe. The event will conclude with a healthy and lively Q&A session.
An archived version of the summer webinar will later be hosted on the IOTOD website.